Measuring bleeding as an outcome in clinical trials of prophylactic platelet transfusions

被引：12
|
作者：
Bercovitz, Rachel S. [1 ]
O'Brien, Sarah H. [2 ,3 ]
机构：
[1] Childrens Hosp Colorado, Aurora, CO USA
[2] Nationwide Childrens Hosp, Res Inst, Ctr Innovat Pediat Practice, Columbus, OH USA
[3] Ohio State Univ, Nationwide Childrens Hosp, Div Pediat Hematol Oncol, Columbus, OH 43210 USA
来源：
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM | 2012年
关键词：
PROSPECTIVE RANDOMIZED-TRIAL; PROGENITOR-CELL TRANSPLANT; ACUTE-LEUKEMIA; THROMBOCYTOPENIA; RECIPIENTS; THRESHOLD; THERAPY;
D O I：
10.1182/asheducation-2012.1.157
中图分类号：
G40 [教育学];
学科分类号：
040101 ; 120403 ;
摘要：
A 12-year-old girl with acute myeloid leukemia has completed her third cycle of chemotherapy and is in the hospital awaiting count recovery. Her platelet count today is 15 000 and, based on your institution's protocol, she should receive a prophylactic platelet transfusion. She has a history of allergic reactions to platelet transfusions and currently has no bleeding symptoms. The patient's mother questions the necessity of today's transfusion and asks what her daughter's risk of bleeding would be if the count is allowed to decrease lower before transfusing. You perform a literature search regarding the risk of bleeding with differing regimens for prophylactic platelet transfusions.
引用
收藏
页码：157 / 160
页数：4
相关论文
共 50 条
  • [1] The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions
    Estcourt, Lise J.
    Heddle, Nancy
    Kaufman, Richard
    McCullough, Jeffrey
    Murphy, Michael F.
    Slichter, Sherrill
    Wood, Erica M.
    Stanworth, Simon J.
    TRANSFUSION, 2013, 53 (07) : 1531 - 1543
  • [2] Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia
    Vinholt, Pernille J.
    Alnor, Anne
    Nybo, Mads
    Hvas, Anne-Mette
    PLATELETS, 2016, 27 (06) : 547 - 554
  • [3] Prophylactic Platelet Transfusions
    Focosi, Daniele
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (22): : 2140 - 2141
  • [4] Prophylactic platelet transfusions
    Pietersz, R. N. I.
    Reesink, H. W.
    Panzer, S.
    Gilbertson, M. P.
    Borosak, M. E.
    Wood, E. M.
    Leitner, G. C.
    Rabitsch, W.
    Ay, C.
    Lambermont, M.
    Deneys, V.
    Sondag, D.
    Compernolle, V.
    Legrand, D.
    Francois, A.
    Tardivel, R.
    Garban, F.
    Sawant, R. B.
    Rebulla, P.
    Handa, M.
    Ohto, H.
    Kerkhoffs, J. -L. H.
    Brand, A.
    Zhiburt, E.
    Cid, J.
    Escolar, G.
    Lozano, M.
    Puig, L.
    Knutson, F.
    Hallbook, H.
    Lubenow, N.
    Estcourt, L.
    Stanworth, S.
    Murphy, M. F.
    Williams, L.
    Mraz, D. L.
    Ross, R. L.
    Snyder, E.
    VOX SANGUINIS, 2012, 103 (02) : 159 - 176
  • [5] Prophylactic platelet transfusions
    Estcourt, Lise J.
    Stanworth, Simon J.
    Murphy, Michael F.
    CURRENT OPINION IN HEMATOLOGY, 2010, 17 (05) : 411 - 417
  • [6] New thoughts on the correct dosing of prophylactic platelet transfusions to prevent bleeding
    Slichter, Sherrill J.
    CURRENT OPINION IN HEMATOLOGY, 2011, 18 (06) : 427 - 435
  • [7] Platelet dose for prophylactic platelet transfusions
    Cid, Joan
    Lozano, Miguel
    EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (04) : 397 - 400
  • [8] Eliminate Prophylactic Platelet Transfusions?
    Slichter, Sherrill J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (19): : 1837 - 1838
  • [9] Platelet count or bleeding as the outcome in ITP trials?
    Arnold, Donald M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (10) : 945 - 946
  • [10] Postoperative bleeding after dentoalveolar surgery in patients with thrombocytopenia—are prophylactic platelet transfusions necessary?
    Johan Lundström
    Samuel Wiqvist
    Martin Jädersten
    Victor Tollemar
    Karin Garming Legert
    Supportive Care in Cancer, 2024, 32 (10)
12345